Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/17689
Title: | Epilepsy. | Austin Authors: | Devinsky, Orrin;Vezzani, Annamaria;O'Brien, Terence J;Jette, Nathalie;Scheffer, Ingrid E ;de Curtis, Marco;Perucca, Piero | Affiliation: | Departments of Neurology, Neuroscience, Neurosurgery and Psychiatry, NYU School of Medicine, New York, NY, USA Laboratory of Experimental Neurology, Department of Neuroscience, IRCCS 'Mario Negri' Institute for Pharmacological Research, Milan, Italy Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia Department of Neurology, Alfred Health, Melbourne, Victoria, Australia Departments of Neurology and Medicine, The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Victoria, Australia Department of Neurology and Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA Epilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia The Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia Department of Paediatrics, The University of Melbourne, and Department of Neurology, The Royal Children's Hospital, Melbourne, Victoria, Australia Epilepsy Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy |
Issue Date: | 3-May-2018 | Date: | 2018-05-03 | Publication information: | Nature reviews. Disease primers 2018; 4: 18024 | Abstract: | Epilepsy affects all age groups and is one of the most common and most disabling neurological disorders. The accurate diagnosis of seizures is essential as some patients will be misdiagnosed with epilepsy, whereas others will receive an incorrect diagnosis. Indeed, errors in diagnosis are common, and many patients fail to receive the correct treatment, which often has severe consequences. Although many patients have seizure control using a single medication, others require multiple medications, resective surgery, neuromodulation devices or dietary therapies. In addition, one-third of patients will continue to have uncontrolled seizures. Epilepsy can substantially impair quality of life owing to seizures, comorbid mood and psychiatric disorders, cognitive deficits and adverse effects of medications. In addition, seizures can be fatal owing to direct effects on autonomic and arousal functions or owing to indirect effects such as drowning and other accidents. Deciphering the pathophysiology of epilepsy has advanced the understanding of the cellular and molecular events initiated by pathogenetic insults that transform normal circuits into epileptic circuits (epileptogenesis) and the mechanisms that generate seizures (ictogenesis). The discovery of >500 genes associated with epilepsy has led to new animal models, more precise diagnoses and, in some cases, targeted therapies. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/17689 | DOI: | 10.1038/nrdp.2018.24 | ORCID: | 0000-0002-2311-2174 | Journal: | Nature reviews. Disease primers | PubMed URL: | 29722352 | Type: | Journal Article |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.